Instituto de Cancerología de Medellín

Instituto de Cancerología de Medellín
Diagonal 75B # 2A-80, Medellín
Select an option
Our team
Medical staff
Noiver Arbey Graciano Vera
Sergio Mejia
Laura Lobo
Maycos Zapata
Ricardo Orozco
Open studies
Bladder Cancer
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy - IMvigor011 - Hoffmann-La RocheSee more
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy